Metabolic syndrome is a cluster of conditions and includes obesity, and can be dangerous as it increases the risk for heart disease, stroke, diabetes and other diseases. In a recent study, published in eLife, researchers ...
Aug 18, 2021
0
329
People using two different inhalers for common chronic lung diseases are more than 50 percent more likely to have a heart attack than those on just one, new University of Otago-led research reveals.
Aug 13, 2021
0
182
According to the American Heart Association (AHA), about 10 percent of the more than 6 million Americans living with heart failure have the advanced form of the disease—where conventional heart therapies and symptom management ...
Aug 11, 2021
0
156
Survival rates after a heart transplant are unaffected if the organ donor had used illicit drugs or died due to an overdose, a fact that is increasing the availability of hearts due to the rise in drug overdose deaths in ...
Jul 28, 2021
0
47
Two types of drugs that are recommended as a first treatment for patients with high blood pressure were found equally effective in improving cardiovascular outcomes, but the more popular type causes slightly more side effects, ...
Jul 26, 2021
0
182
French company Carmat announced its first human artificial heart implant in the United States on Thursday, as part of a clinical study.
Jul 15, 2021
0
5
Federal officials said Wednesday they plan to strengthen cautions about a rare side effect of some COVID-19 vaccines—chest pain and heart inflammation, mostly among teenagers and young adults.
Jun 24, 2021
0
2
(HealthDay)—Living longer often means living with multiple health problems and numerous medications to manage them. Understandably, many doctors and their patients wonder if any of these drugs can be discontinued safely.
Jun 14, 2021
0
4
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or ...
May 17, 2021
0
10
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse ...
May 17, 2021
0
4
